JMP Securities Downgrades iBio to Market Perform
JMP Securities analyst Roy Buchanan downgrades iBio (AMEX:IBIO) from Market Outperform to Market Perform.
Akamai Leaves Analysts Concerned Following Aggressive Shift To Computing, A Field Dominated By AWS, Azure, GCP
RBC Capital analyst Rishi Jaluria downgraded Akamai Technologies Inc (NASDAQ:AKAM) from Outperform to Sector Perform and reduced the price target from $100…
Keefe, Bruyette & Woods Downgrades Triton International to Market Perform, Announces $74 Price Target
Keefe, Bruyette & Woods analyst Michael Brown downgrades Triton International (NYSE:TRTN) from Outperform to Market Perform and announces $74 price target.
Tudor Pickering Downgrades Ford Motor to Hold
Tudor Pickering analyst Jeoffrey Lambujon downgrades Ford Motor (NYSE:F) from Buy to Hold.
JP Morgan Downgrades GCM Grosvenor to Neutral, Announces $9 Price Target
JP Morgan analyst Kenneth Worthington downgrades GCM Grosvenor (NASDAQ:GCMG) from Overweight to Neutral and announces $9 price target.
Benchmark Downgrades Howmet Aerospace to Hold
Benchmark analyst Josh Sullivan downgrades Howmet Aerospace (NYSE:HWM) from Buy to Hold.
Evercore ISI Group Downgrades Marriott Intl to In-Line, Announces $180 Price Target
Evercore ISI Group analyst Duane Pfennigwerth downgrades Marriott Intl (NASDAQ:MAR) from Outperform to In-Line and announces $180 price target.
Citigroup Downgrades Bath & Body Works to Neutral, Lowers Price Target to $48
Citigroup analyst Paul Lejuez downgrades Bath & Body Works (NYSE:BBWI) from Buy to Neutral and lowers the price target from $50 to $48.
Bernstein Downgrades Oak Street Health to Market Perform, Raises Price Target to $39
Bernstein analyst Lance Wilkes downgrades Oak Street Health (NYSE:OSH) from Outperform to Market Perform and raises the price target from $35 to $39.
Cowen & Co. Downgrades Credo Technology Group to Market Perform, Announces $11 Price Target
Cowen & Co. analyst Matt Ramsay downgrades Credo Technology Group (NASDAQ:CRDO) from Outperform to Market Perform and announces $11 price target.